SCHEMBL5569897

SCHEMBL5569897

CCCOc1ccc(NC(=O)C(Cc2ccc(OCc3ccccc3)cc2)NS(=O)(=O)N(C)C)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 1/20 0.51
PTPN12 Q05209 1/20 0.51
PTPN13 Q12923 1/20 0.51
SSU72 Q9NP77 1/20 0.51
AR P10275 1/20 0.46
MAPT P10636 3/20 0.44
LTA4H P09960 1/20 0.44
PNLIP P16233 1/20 0.43
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
TSHR P16473 1/20 0.42
MMP9 P14780 1/20 0.42
MMP8 P22894 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
TNF P01375 1/20 0.41
NOD2 Q9HC29 1/20 0.41
NOD1 Q9Y239 1/20 0.41
MME P08473 1/20 0.41
ACE P12821 1/20 0.41
CPA1 P15085 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5569895 0.89 ACP1 (0.50) ACP1PTPN12PTPN13SSU72AR
SCHEMBL4776505 0.84 MMP9 (0.52) ACP1PTPN12PTPN13SSU72LTA4H
SCHEMBL4778789 0.83 LTA4H (0.55) ACP1PTPN12PTPN13SSU72LTA4H
SCHEMBL14421645 0.83 RORC (0.44) ACP1PTPN12PTPN13SSU72MAPT
SCHEMBL4776502 0.73 CENPE (0.56) ACP1PTPN12PTPN13SSU72LTA4H
SCHEMBL14417653 0.71 HDAC8 (0.56) HDAC8BCL2
SCHEMBL4778783 0.71 LTA4H (0.56) ACP1PTPN12PTPN13SSU72LTA4H
SCHEMBL4884258 0.69 CSNK2A1 (0.55) LTA4HALDH1A1
SCHEMBL18289708 0.69 ACP1 (1.00) ACP1PTPN12PTPN13SSU72MAPT
SCHEMBL11358766 0.69 PNLIP (0.51) MAPTPNLIPPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219192-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-09-20 US claimed
US-20070219192-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219192-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 ACP1 314/4885PTPN12 4182/4885PTPN13 3950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.